| Product Code: ETC4759207 | Publication Date: Nov 2023 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Vaccines Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Vaccines Market - Industry Life Cycle |
3.4 Mauritius Vaccines Market - Porter's Five Forces |
3.5 Mauritius Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Mauritius Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Mauritius Vaccines Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Mauritius Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Mauritius Vaccines Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 Mauritius Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Vaccines Market Trends |
6 Mauritius Vaccines Market Segmentations |
6.1 Mauritius Vaccines Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Vaccines Market Revenues & Volume, By Conjugate vaccines, 2021-2031F |
6.1.3 Mauritius Vaccines Market Revenues & Volume, By Inactivated and subunit vaccines, 2021-2031F |
6.1.4 Mauritius Vaccines Market Revenues & Volume, By Live attenuated vaccines, 2021-2031F |
6.1.5 Mauritius Vaccines Market Revenues & Volume, By Recombinant vaccines, 2021-2031F |
6.1.6 Mauritius Vaccines Market Revenues & Volume, By Toxoid vaccines, 2021-2031F |
6.2 Mauritius Vaccines Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Vaccines Market Revenues & Volume, By Monovalent vaccines, 2021-2031F |
6.2.3 Mauritius Vaccines Market Revenues & Volume, By Multivalent vaccines, 2021-2031F |
6.3 Mauritius Vaccines Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Vaccines Market Revenues & Volume, By Pneumococcal disease, 2021-2031F |
6.3.3 Mauritius Vaccines Market Revenues & Volume, By DTP, 2021-2031F |
6.3.4 Mauritius Vaccines Market Revenues & Volume, By Influenza, 2021-2031F |
6.3.5 Mauritius Vaccines Market Revenues & Volume, By HPV, 2021-2031F |
6.3.6 Mauritius Vaccines Market Revenues & Volume, By Meningococcal disease, 2021-2031F |
6.3.7 Mauritius Vaccines Market Revenues & Volume, By Polio, 2021-2031F |
6.3.8 Mauritius Vaccines Market Revenues & Volume, By Other disease indications, 2021-2031F |
6.3.9 Mauritius Vaccines Market Revenues & Volume, By Other disease indications, 2021-2031F |
6.4 Mauritius Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Mauritius Vaccines Market Revenues & Volume, By Intramuscular and subcutaneous administration, 2021-2031F |
6.4.3 Mauritius Vaccines Market Revenues & Volume, By Oral administration, 2021-2031F |
6.4.4 Mauritius Vaccines Market Revenues & Volume, By Other routes of administration, 2021-2031F |
6.5 Mauritius Vaccines Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 Mauritius Vaccines Market Revenues & Volume, By Pediatric patients, 2021-2031F |
6.5.3 Mauritius Vaccines Market Revenues & Volume, By Adult patients, 2021-2031F |
7 Mauritius Vaccines Market Import-Export Trade Statistics |
7.1 Mauritius Vaccines Market Export to Major Countries |
7.2 Mauritius Vaccines Market Imports from Major Countries |
8 Mauritius Vaccines Market Key Performance Indicators |
9 Mauritius Vaccines Market - Opportunity Assessment |
9.1 Mauritius Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Mauritius Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Mauritius Vaccines Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Mauritius Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Mauritius Vaccines Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10 Mauritius Vaccines Market - Competitive Landscape |
10.1 Mauritius Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here